Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Gaia Bianco¹, Mairene Coto-Llerena^{1

2}, John Gallon¹, Venkatesh Kancherla², Stephanie Taha-Mehlitz¹, Mattia Marinucci¹, Martina Konantz³, Sumana Srivatsa⁴, Hesam Montazeri^{2

5}, Federica Panebianco¹, Vijaya G Tirunagaru⁶, Marta De Menna⁷, Viola Paradiso^{1

2}, Caner Ercan², Ahmed Dahmani⁸, Elodie Montaudon⁸, Niko Beerenwinkel⁴, Marianna Kruithof-de Julio⁷, Luigi M Terracciano^{2

9

10}, Claudia Lengerke³, Rinath M Jeselsohn¹¹, Robert C Doebele⁶, François-Clément Bidard¹², Elisabetta Marangoni⁸, Charlotte K Y Ng^{13

14

15}, Salvatore Piscuoglio^{16

17}

Affiliations

¹ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
² Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
³ Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
⁴ Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
⁵ Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
⁶ Rain Therapeutics Inc, Newark, CA, USA.
⁷ Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
⁸ Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
⁹ Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
¹⁰ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
¹¹ Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
¹² Department of Medical Oncology, Institut Curie, Saint Cloud, France.
¹³ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁴ Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁵ SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁶ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. s.piscuoglio@unibas.ch.
¹⁷ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. s.piscuoglio@unibas.ch.

PMID: 35787660
PMCID: PMC9253331
DOI: 10.1038/s42003-022-03612-5

Published Erratum

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Gaia Bianco et al. Commun Biol. 2022.

. 2022 Jul 4;5(1):658.

doi: 10.1038/s42003-022-03612-5.

Authors

Affiliations

¹ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
² Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
³ Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
⁴ Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
⁵ Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
⁶ Rain Therapeutics Inc, Newark, CA, USA.
⁷ Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
⁸ Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
⁹ Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
¹⁰ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
¹¹ Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
¹² Department of Medical Oncology, Institut Curie, Saint Cloud, France.
¹³ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁴ Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁵ SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. charlotte.ng@dbmr.unibe.ch.
¹⁶ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. s.piscuoglio@unibas.ch.
¹⁷ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. s.piscuoglio@unibas.ch.

PMID: 35787660
PMCID: PMC9253331
DOI: 10.1038/s42003-022-03612-5

No abstract available

PubMed Disclaimer

Erratum for

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Bianco G, Coto-Llerena M, Gallon J, Kancherla V, Taha-Mehlitz S, Marinucci M, Konantz M, Srivatsa S, Montazeri H, Panebianco F, Tirunagaru VG, De Menna M, Paradiso V, Ercan C, Dahmani A, Montaudon E, Beerenwinkel N, Kruithof-de Julio M, Terracciano LM, Lengerke C, Jeselsohn RM, Doebele RC, Bidard FC, Marangoni E, Ng CKY, Piscuoglio S. Bianco G, et al. Commun Biol. 2022 Apr 19;5(1):373. doi: 10.1038/s42003-022-03296-x. Commun Biol. 2022. PMID: 35440675 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Affiliations

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials